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NA-methylation status represents one of the most frequent epigenetic modifications controlling gene-expression patterns in normal cells (1) . Therefore, it should be noted that hypomethylation-mediated oncogene activation, and conversely hypermethylation-mediated tumor suppressor gene (TSG) silencing, would provide an important platform for understanding development of cancer (1, 2) . DNA-methylation is catalyzed by DNA methyltransferase (DNMT) enzymes, identified as DNMT1, DNMT3A, and DNMT3B (2) . DNMT1 has been shown to be involved in maintaining overall methylation density in cells, whereas DNMT3A and DNMT3B function as de novo methyltransferase enzymes (2) . A fourth DNMT enzyme, DNMT2, lacks proper DNA-methylating catalytic activity (2, 3) . Although elevated expression of one or all DNMTs has been reported in a number of cancer cell types (1) , the degree to which they are precisely involved in tumor growth remains somewhat unclear.
Human tumor virus infections can result in modulation of expression of DNMTs; however, there is no particular trend (4, 5) . For example, the hepatitis B virus-encoded X protein elevates expressions of DNMT1 and DNMT3A, and represses DNMT3B (6) . In contrast, hepatitis C virus-encoded core protein up-regulates both DNMT1 and DNMT3B (6) . However, the human papillomavirus-encoded E6 protein up-regulates only DNMT1 (7) . Furthermore, the Kaposi's sarcoma-associated herpesvirusencoded LANA protein up-regulates only DNMT3A (8) . In contrast, one of the essential Epstein-Barr virus (EBV) -encoded latent proteins, LMP1, was shown to up-regulate all three DNMTs in nasopharyngeal carcinoma (NPC) cell lines (9, 10) , but downregulates DNMT1 in germinal center B-cell-derived malignancies, such as Hodgkin's lymphoma (4) . LMP1 can also induce methylation of the TSGs, RARB and CDH13, thereby blocking their transcription in NPC-lines (10) . Another EBV-encoded latent nuclear membrane protein, LMP2A, was also shown to induce DNMT1 expression, and subsequently increase the methylation of the phosphatase and tensin homolog deleted on chromosome 10 (PTEN) TSG, in gastric cancer (GC) cell lines (11) . The precise role of other EBV latent antigens in the epigenetic deregulation of the cellular genome, including expression of TSGs, remains largely unexplored.
Evidence to date has demonstrated that expression of TSGs is strongly associated with promoter hypermethylation in EBVassociated GC (12) . However, modulation of DNMT expression on EBV infection, and subsequently expression of TSGs in primary B lymphocytes, has not yet been fully explored. Importantly, in vitro EBV infection of resting B-cells leads to continuously proliferating lymphoblastoid cell lines (LCLs), which serve as an attractive surrogate model for investigating the underlying molecular mechanisms in developing several EBV-associated B-cell proliferative disorders, including immunoblastic lymphoma and posttransplant lymphoproliferative disorder in immune-competent as well as immune-suppressed individuals.
In this report, we investigated the acquisition of DNA-methylation changes in the regulatory regions of TSGs during EBVinduced primary B-cell transformation leading to continuously proliferating LCLs. Our results now suggest a model where in vitro EBV infection leads to overall transcriptional repression of TSGs through enhanced methylation at their CpG islands. Further in depth analysis of other epigenetic alterations, including histone modifications associated with EBV-induced B-cell transformation, may result in a more comprehensive understanding of Significance Aberrant promoter methylation of tumor suppressor genes (TSGs) has been found in a large number of human cancers, including Epstein-Barr virus (EBV)-associated cancers. However, how epigenetic modification controls TSG expression in primary B lymphocytes in response to EBV infection has not been fully investigated. In vitro EBV readily transforms quiescent B-cells into lymphoblastoid cell lines, providing a working model for understanding the underlying molecular mechanisms of B-cell lymphoma development. To our knowledge, our work represents the first report to demonstrate that EBV-infection of naïve B lymphocytes resulted in global transcriptional repression of TSGs through recruitment of hypermethylation activities at CpG islands. These results can be further used as potential prognosticmarkers and for current therapeutic enhancements against acuteinfection and EBV-associated B-cell lymphomas.
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B-cell lymphoma development to facilitate current therapeutic interventions.
Results

EBV Infection of Human Primary B Cells Leads to Aberrant Methylation
of Cellular Genes. Studies have shown that EBV hijacks the cellular methylating machinery to regulate the gene-expression program, which is important for driving transformation of infected cells (13) .
This includes promoter regions of hypomethylated oncogenes as well as hypermethylated TSGs (12, 14) . However, the underlying mechanism by which EBV triggers primary resting B lymphocytes toward uncontrolled cell proliferation is not fully understood.
To explore the overall changes in cellular DNA-methylation associated with EBV-induced B-cell transformation, fresh peripheral blood mononuclear cells (PBMCs) from healthy individuals were infected with GFP-tagged EBV generated from a stably infected BACmid HEK293T cell line (15) for a period of 15 d. To monitor EBV infection, GFP fluorescence of infected PBMCs was assessed using fluorescence microscopy (Fig. S1 ). Because genetic variants may also be associated with the disparity of gene expressions, PBMCs were collected from three independent donors. Total genomic DNA was isolated from infected PBMCs at different times of postinfection (0, 2, 7, and 15 d) and subjected to methylation profiling (Fig. 1) . A total of 96 gene-promoter sequences from three independent samples were evaluated (Table  S1 ). We used the "Tumor Suppressor Genes DNA Methylation PCR Array" gene set from SABiosciences. The categories of these 96 genes are shown in Table S2 . As expected, our results demonstrated that EBV infection led to an overall change in cellular methylation status of CpG islands (Fig. 1 ). An analogous pattern was observed in results from all three respective donors (Table S3) , as shown in the representative dataset from donor 1 (Fig. 1 ). Data analysis was carried out using an algorithm provided by SABiosciences, which included the quality check to include or exclude real-time PCR data points for individual genes. The relative change in the percent methylation is represented with respect to the day 0 control sample. Change in the methylation status is displayed as a heat map normalized separately for individual gene promoters (Fig. 1) . The results showed that by 15-d postinfection the regions were highly methylated, suggesting a role for EBV antigens in inducing methylation of the represented cellular genes.
In Vitro EBV Infection Causes Global Transcriptional Repression of
TSGs. To assess the distribution of methylation values in uninfected resting PBMCs and in vitro virally infected PBMCs, we calculated the percent methylation value for each promoter and subsequently plotted using an excel sheet to generate the heat map ( Fig. 1) . The results are depicted as four significantly different categories that represented the methylation patterns: (i) gain of methylation, (ii) loss of methylation, (iii) distinct methylation status, and (iv) fluctuating methylation status. The third category is distinct in such a way that the methylation status of many promoters in this category was significantly up-regulated by 2-d infection followed by down-regulation and vice versa. This might be because of EBV hyperproliferation, as demonstrated earlier by Nikitin et al. (16) . The third category included 25 genes: ABL1, CAV1, CCND2, CDH13, CDX2, DKK3, DLC1, E2F1, GSTP1, IGF2, IGF2R, NFKB1, PTEN, PTGS2, RASSF1, SFN, SLC5A8, MEN1, TERT, TIMP3, TSC1, TSC2, VHL, WWOX, and ZMYND10 (Fig. 1) . Genes with increasing methylation status included 40 genes: ABCB1, AKT1, ATM, BCL2, BRAF, CADM1, CDKN1A, CDKN1B, CDKN2A, CDKN2B, CTNNB1, DAPK1, DIRAS3, EGFR, ERBB2, HIC1, HRAS, ING1, MDM2, MGMT, MLH1, MYCN, NF1, NF2, NME1, OPCML, PRDM2, PTCH1, RB1, RET, RUNX3, SCGB3A1, SFRP2, SH3PXD2A, SMARCB1, TGFB1, TGFBR2, THBS1, TP53, and TP73 ( Fig. 1) . Only six candidate genes showed methylation status with decreasing trend: APC, HOXA1, MYC, SFRP1, SOCS1, and WT1 (Fig. 1) . The fourth category included 25 genes that showed a fluctuating methylation profile over the 15-d postinfection. These are: BCR, BIRC5, BRCA1, BRCA2, CCND1, CD44, CDH1, CDKN1C, CDKN3, CHFR, DAB2IP, ESR1, FAS, FHIT, FOS, JUN, LOX, NEUROG1, PDLIM4, PYCARD, RARB, SMAD4, VEGFA, WIFI, and XRCC1 (Fig. 1) .
To corroborate the methylation profile into transcriptional profile, we further selected a total of 29 genes covering all four categories, which were subsequently subjected to real-time PCR analyses using a similar experimental setting (Fig. 1, red) . The primers for quantitative PCR of the selected genes are listed in Table S4 . The selected genes were categorized into three groups, which included cell-cycle (20 genes), apoptosis (14 genes), and DNA-damage repair (10 genes) (Fig. 2 A-C) . In addition, a total of five viral transcripts-including BZLF1, EBNA1, EBNA2, EBNA3C, and LMP1-were also analyzed to confirm EBV infection of the primary B lymphocytes (Fig. 2D) , as previously described (15) . As expected, BZLF1 expression at 2-d postinfection indicated a lytic mode of infection followed by a latent period as seen by a loss of signal by 15-d postinfection (Fig. 2D) . The establishment of latency was also demonstrated by steady expression levels of EBNA1, EBNA2, EBNA3C, and LMP1 throughout 15 d of postinfection (Fig. 2D , yellow to green). As described above, the real-time PCR data from resting (0 d) along with different time points (2, 7, 15 d) of EBV-infected PBMCs were analyzed and presented as a heat map (Fig. 2 A-C) . The results demonstrated that the transcription profiles of the selected genes were inversely proportional to that of methylation-profiles (compare Figs. 1 and 2 ). This finding indicated that in vitro EBV infection of resting B lymphocytes can globally repress TSGs expression through regulation of their CpG methylation status.
In Vitro EBV Infection Is Associated with Deregulation of ChromatinModifying and -Remodeling Factors. Chromatin-modifying enzymes and chromatin-remodeling factors are differentially expressed in tumor cells compared with normal cells. This finding suggests a critical role for these genes in driving the oncogenic process, including development of EBV-associated B-cell lymphoma (17, 18) . Similar to studies described above, the total cDNA was generated from uninfected and infected B cells at the indicated time points and subjected to PCR-array analyses for epigenetic chromatin-modification enzymes and human epigenetic chromatin-remodeling factors ( Fig. 3 A and B, respectively) .
The results demonstrated a global transcriptional alteration of these genes in both the chromatin-modifying and chromatinremodeling categories in response to EBV infection of resting B lymphocytes ( Fig. 3 A and B, respectively) . The results showed that the transcript levels of de novo DNA methyltransferase enzymes DNMT3A and DNMT3B, but not DNMT1, gradually increased in response to EBV infection of resting B cells (Fig.  3A) . Interestingly, the transcript levels of DNA CpG-methyl binding domain (MBD) genes MBD1, MBD3, MBD4, and MeCP2, except MBD2 were significantly down-regulated (Fig. 3B) . In addition, the histone deacetylase enzymes (HDACs 1-11) were in general, notably up-regulated by 2-d postinfection and maintained the level throughout the course of infection (Fig. 3A) .
The exclusion of acetyl groups by HDACs facilitates chromatin compaction and thus causes transcriptional inhibition (19) . To corroborate the data above we further selected these genes (Fig. 3, red) and performed real-time PCR analyses using a similar in vitro infection set-up as well as compared transcripts from established LCLs with resting B cells (Fig. 4 A and B , Upper and Lower, respectively). The results further showed that EBV infection specifically elevated DNMT3B expression along with DNMT3L during the course of infection, but not DNMT1 or DNMT2 (Fig. 4A) . We chose DNMT2 in this category because of its sequence homology to other DNMTs (20) . However, the specific catalytic domain for DNA methylation has not been identified; rather, DNMT2 has been found to methylate RNA instead of DNA (20) . In contrast, having sequence homology to both DNMT3A and DNMT3B, and with no catalytic domain, DNMT3L was found to enhance their de novo DNMT activities by increasing their ability to bind to the methyl group donor, S-adenosyl-L-methionine (20) . In both experimental set-ups DNMT3A was expressed at a lower level compared with DNMT3B and DNMT3L, suggesting that EBV infection of primary B lymphocytes specifically recruited a complex of DNMT3B/3L to regulate cellular gene expression (Fig. 4A) . Interestingly, we could not find any specific differences in HDAC expression level but rather a full-blown induction of all 11 HDACs in response to EBV infection of primary B cells (Fig. 4B) .
Expression patterns of MBDs, DNMTs, and HDACs were also extended using EBV − (BJAB and BL41) and EBV + (Jijoye and BL41-B95.8) Burkitt's lymphoma (BL) cells (Fig. S2) . The results demonstrated that the expression pattern of both MBDs, except MeCP2, and HDACs, closely resembled that of primary B-lymphocyte infection. Interestingly, MeCP2 was shown to be up-regulated in EBV + BL cells in comparison with negative lines (Fig. S2) . However, in contrast, the expression pattern of DNMTs in EBV + BL lines showed a rather stochastic pattern (Fig. S2 ). This result might be because of differences that exist in the genetic background of the different BL cells compared with primary infection using PBMCs isolated from healthy individuals. Overall, these results provide additional clues that chromatinmodifying and -remodeling factors may function in collaboration with methylation activities to regulate TSG expression during EBV infection of primary B cells. Elucidating the underlying mechanisms would increase our understanding of EBV-associated B-cell lymphomagenesis (Fig. 4C, model) .
Inhibition of DNMT Activity Accelerates Gene Transcription in Infected B Cells. To further validate this model, transcription analyses were performed on a comprehensive list of TSGs in the presence and absence of the DNMT inhibitor, 5′-azacytidine (Aza) using in vitro EBV-transformed LCLs (LCL1, LCL2, and GFP-LCLs) in addition to EBV-infected PBMCs at 7-d postinfection (Fig. 5A) . Aza is a potent DNMT inhibitor (14, 20) , and is associated with lytic cycle activation in EBV-transformed B cells through demethylation of BZLF1 and BRLF1 viral gene promoter sequences (21) . As expected, association of methyl groups with the CpG elements of selected promoters appeared to be significantly deactivated (P < 0.001) in the presence of the methyltransferase inhibitor, which as a result demonstrated an increase in transcription in each experiment (yellow to green, Fig. 5A, Upper) . However, Aza treatment did not cause any transcriptional alteration of DNMT1 (green to green, Fig. 5A , Upper), suggesting that either DNMT1 itself is not regulated by methylation or that its expression levels were already at maximum. Interestingly, Aza treatment caused an overall transcriptional activation of all of the selected viral genes, including both lytic gene BZLF1 to four different latent genes, EBNA1, EBNA2, EBNA3C, and LMP1 (Fig. 5A, Lower) . The results implied that DNA methylation plays an important role not only in regulating cellular gene expression but also to critically participate in temporal expression of viral genes. To corroborate the impact of deregulated TSGs Fig. 2 . Gene-expression analyses of selected TSGs and viral transcripts in response to EBV infection of resting PBMCs. In a similar experimental set-up as described in Fig. 1 , total RNA was isolated at indicated days (0-, 2-, 7-, and 15-d postinfection) from resting PBMCs infected with BAC-GFP-EBV, converted to cDNA, and subjected to real-time PCR for the indicated cellular (A-C) and viral transcripts (D) using SYBR green PCR master mix as per the manufacturer's protocol. Similar experiments were carried out for three independent donors and a representative figure is shown from donor 2. Relative transcriptional changes are represented with respect to the day 0 uninfected sample, and displayed as a heat map normalized separately for individual gene expressions.
and viral gene-expression profiles in response to Aza on EBVinfected lymphoblastoid cell growth, we further performed cell proliferation and cell viability assays using three different LCLs, as indicated (Fig. 5B) . The results demonstrated that Aza treatment caused a drastic reduction of both cell growth and cell viability in comparison with DMSO controls (Fig. 5B , Left and Right, respectively).
Taken together, these data provide, to our knowledge, the first evidence of the importance of specific DNA methylating enzymes in regulating transcription of TSGs during EBV infection of primary B lymphocytes. This finding offers insight into the hierarchy of the cellular machinery required to establish latent viral infection followed by development of B-cell lymphoma.
Discussion
Epigenetic mechanisms including C5-methylation at CpG dinucleotides, and the covalent histone modification through the attachment of acetyl-, methyl-, or phosphate groups, which leads Fig. 3 . PCR array analysis for chromatin-modification enzymes and chromatin-remodeling factors in response to EBV infection in resting PBMCs. In a similar experimental set-up as described in Figs. 1 and 2 , total RNA was isolated from ∼10 million PBMCs infected with BAC-GFP-EBV at different time points (days 0, 2, 7, and 15 postinfection), cDNA was made and subjected to PCR array analyses using (A) "Epigenetic Chromatin Modification Enzymes PCR Array" and (B) "Human Epigenetic Chromatin Remodeling Factors PCR Array" from SABiosciences, according to the manufacturer's instructions for two independent donors. The relative changes in transcripts using the 2 −ΔΔCt method were represented as a heat map in comparison with the day 0 uninfected sample control for donor 1. The red marked transcripts-particularly HDACs, DNA methyl transferases, and methyl binding proteins-were chosen for further analyses.
to either transcriptional repression or activation, play an indispensable role in development of human cancers. Tumor viruses contribute to ∼20% of all human cancers (22, 23) . Epstein-Barr virus, one of the prominent human oncogenic viruses associated with a number of epithelial and lymphoid cancers (23, 24) , is an excellent model system to investigate the epigenetic reprogramming events that occur during in vitro B-cell transformation important for development of LCLs.
Earlier studies primarily focused on delineating the epigenetic mechanisms that orchestrate silencing of EBV latency gene expression during establishment of latency programs within B lymphocytes and subsequent reactivation of lytic genes (4, 14, 25) . However, there were no studies demonstrating how EBV reprograms the cellular gene-expression profiles during primary B-cell infection, which eventually leads to B-cell lymphomagenesis. In this study, we investigated the acquisition of DNA-methylation in CpG islands of TSGs during EBV infection of primary B-cell transformation. As seen in most human cancers, including EBVassociated cancers (14) , our results also showed deregulation of tumor suppressors and cell-cycle checkpoints at both G1/S and G2/M transitions, namely Rb1/E2F1 and TP53/MDM2 arms, through alteration of CpG methylation. We and others have previously shown that EBV infection and expression of a number of viral latent proteins can specifically target these two important tumor-suppressor arms through multiple mechanisms (24, (26) (27) (28) . We now provide further clues that demonstrate additional molecular mechanisms, which regulate TSG expression and therefore contribute to subsequent B-cell transformation.
Although the overall degree of DNA methylation decreases with tumor progression, the methylation frequency at CpG islands and histone modifications is increased (29) . Methylation patterns at CpG islands are now considered a hallmark of cancer development (29) . Furthermore, epigenetic imbalance of both oncogenes and TSGs are associated with a number of EBVassociated cancers, including BL, Hodgkin's lymphoma (HL), NPC, and GC (11) (12) (13) (14) . Indeed, TSGs in general were found to often be inactivated through CpG-methylation compared with overall mutations (29) . CpG methylation of TSGs thus could be used as prognostic markers as well as development of potential therapeutic avenues in EBV-associated cancers. In agreement with this, our results depicted a similar outcome and suggested a 5 LCL clones were plated into each well of the six-well plates, exposed to either 1 μM Aza or DMSO vehicle control treatment for 3 d at 37°C humidified CO 2 chamber. Cell viability was determined through the Trypan blue exclusion method and only viable cells were counted every 24 h using an automated cell counter. Experiments were performed in duplicate and repeated two times.
model where in vitro EBV infection of primary B lymphocytes led to significant changes in the methylation profile of TSGs, which ultimately contributes to development of B-cell lymphoma.
A number of genome-wide differential screens for methylated genes were previously performed in response to methyltransferase inhibitor (Aza) -treated EBV + GC lines compared with nontreated cells, along with various EBV-linked GC tissue samples (12, 30) . The results demonstrated that several TSGs had an elevated methylation pattern in the primary GC samples (30) . For example, elevated methylation of CDKN2A, GSTP1, TP73, and HOXA10 was shown to be associated with EBVassociated GC tissue samples (30) , suggesting that EBV induces global epigenetic disruption of the cellular genome in development of GC. Interestingly, our results reflected a similar elevated methylation pattern of these genes on EBV infection of PBMCs. Likewise, differential gene expression and microarray analyses on various EBV + NPC tissue samples, along with other established cell lines, demonstrated a number of TSGs with a high frequency of methylation (31) . These include CDH1 (E-cadherin), OPCML, the metalloproteases ADAMTS9 and ADAMTS18, Lactotransferrin (LTF), IRF8 (IFN regulatory factor 8), EDNRB (endothelin receptor type B), RASAL (Ras GTPase-activating-like protein), CMTM5 (CKLF-like MARVEL transmembrane domain containing member 5), RASSF1A, RARβ2 (retinoic acid receptor ß2), cellular retinol binding proteins CRBP1 and CRBP4, and RARRES/TIG1 (retinoic acid receptor responder/tazarotene induced gene 1) (14, (32) (33) (34) . Interestingly, the OPCML gene (opioid binding protein/cell adhesion molecule-like) was earlier shown to be highly methylated in NPC, BL, and HL (35) . Our results show a similar trend in OPCML CpG methylation on EBV infection of PBMCs, indicating that inactivation of OPCML transcription is highly associated with development of EBV-associated cancers from epithelial as well as lymphoid origin. In contrast, methylation of RARB and RASSF1 did not show any specific pattern. Compared with these endothelial carcinomas, a similar approach was conducted in the EBV-associated B-cell lymphomas BL and HL, using microarray technologies (36, 37) . Broad-spectrum TSGs and genes involved in cell-cycle control, apoptosis, intracellular signaling, proliferation, and surface adhesion were frequently methylated in BL tumors, such as CCND2, CDKN1C (p57/kinase inhibitor protein 2), GADD45G (growth arrest and DNA damage inducible 45G), PLK2 (Polo-like serine-threonine kinase 2), FHIT (fragile histidine triad), MAPK10/JNK3 (mitogen activated protein kinase 10/jun N-terminal kinase 3), PTPN13/ FAP1 (protein tyrosine phosphatase), Wnt-signaling inhibitor WNT5A, proto-cadherin 10 (PCDH10), DLC1 (deleted in liver cancer 1) (14, 37) . Interestingly, the methylation pattern of CCND2, CDKN1C, FHIT, and DLC1 showed a similar trend as demonstrated in this study. Similarly, a tissue microarray analysis on multiple HL biopsies showed that Hodgkin and ReedSternberg tumor cells harbor multiple alterations of major tumorsuppressor pathways and cell-cycle checkpoints (36) . In contrast to BL, DAPK (death associated protein kinase) was found to be methylated at a low frequency in HL tissues (38) , as well as in our studies at a much later stage during infection.
Several lines of evidence have earlier shown that the NF-κB signaling pathway plays a major role in EBV induced B-cell proliferation (39) . However, in contrast, the precise role of NF-κB signaling during the early stages of EBV-infection of naïve B lymphocytes has not been studied extensively. Recently it has been shown that NF-κB targeted gene expression was attenuated during the early stages of infection (39) . In agreement with this, our data also demonstrated a significant elevation of NF-κB promoter methylation by 15-d postinfection, which resulted in its delayed expression. Therefore, NF-κB signaling is important in maintenance of B-cell outgrowth and primary B-cell immortalization.
We now provide evidence for EBV-mediated differential recruitment of DNMT activities to regulate TSGs expression during B-cell transformation. A large number of TSGs involved in regulating a number of cellular signaling pathways were analyzed to determine their methylation status in response to EBV infection of naïve B lymphocytes. As discussed above, the methylation pattern of these TSGs were congruent with other EBVassociated tumors, demonstrating the differential methylation patterns of a large number of novel TSGs. Further analysis of the overall epigenetic reprogramming events and delineation of the specific roles of EBV latent antigens in epigenetic deregulation of the cellular genome will provide a more comprehensive understanding of the molecular mechanisms linked to viral pathogenesis, foremost during the period of early infection. Importantly, this work provides avenues for subsequent prognostic and therapeutic strategies targeting EBV-associated malignancies. The GFP-LCL clone #10 is also human peripheral B cells transformed with BAC-GFP-EBV, as previously described (15) .
Infection of PBMCs with BAC-GFP-EBV. PBMCs from healthy donors were obtained from University of Pennsylvania Immunology Core as previously described (15) . Please refer to SI Materials and Methods for detailed descriptions of experimental procedures.
